Drug discovery and development: the role of artificial intelligence in drug repurposing

Mohamad Aljofan,Abduzhappar Gaipov

DOI: https://doi.org/10.4155/fmc-2024-0048

2024-03-02

Future Medicinal Chemistry

Abstract:Keywords: AI big data drug development Drug discovery repurposing References 1. Emily May LG, Karen T, Wendell M . Measuring the return from pharmaceutical innovation 2022 . Deloitte ( 2023 ). www2.deloitte.com/us/en/pages/life-sciences-and-health-care/articles/measuring-return-from-pharmaceutical-innovation.html Google Scholar 2. Berdigaliyev N, Aljofan M . An overview of drug discovery and development . Future Med. Chem. 12(10), 939–947 ( 2020 ).CAS Google Scholar 3. Scannell JW, Blanckley A, Boldon H, Warrington B . Diagnosing the decline in pharmaceutical R&D efficiency . Nat. Rev. Drug Discov. 11(3), 191–200 ( 2012 ).Medline CAS Google Scholar 4. Jensen EJ . Research expenditures and the discovery of new drugs . J. Ind. Econ. 36(1), 83–95 ( 1987 ). Google Scholar 5. Jentzsch V, Osipenko L, Scannell JW, Hickman JA . Costs and causes of oncology drug attrition with the example of insulin-like growth factor-1 receptor inhibitors . JAMA Netw. Open 6(7), e2324977 ( 2023 ).Medline Google Scholar 6. AI's potential to accelerate drug discovery needs a reality check . Nature 622(7982), 217 ( 2023 ).Medline Google Scholar 7. Ringel MS, Scannell JW, Baedeker M, Schulze U . Breaking Eroom's law . Nat. Rev. Drug Discov. 19(12), 833–834 ( 2020 ).Medline CAS Google Scholar 8. WadmanM . Merck settles Vioxx lawsuits for $4.85 billion . Nature doi: 10.1038/450324b ( 2007 ). Google Scholar 9. Guengerich FP . Mechanisms of drug toxicity and relevance to pharmaceutical development . Drug Metab. Pharmacokinet. 26(1), 3–14 ( 2011 ).Medline CAS Google Scholar 10. van der Pol KH, Aljofan M, Blin O et al. Drug repurposing of generic drugs: challenges and the potential role for government . Appl. Health Econ. Health Policy 21(6), 831–840 (

chemistry, medicinal